Skip to main content

Advertisement

Table 1 Comparison of baseline characteristics in case and control group

From: The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment

Variable HIV+TB (Cases: N = 63) HIV+ (Controls: N = 51) P value
Age (years) Mean, IOR a 36.5 (24-60) 37.2 (25-57) 0.67
Gender Males Females 49 (77.7%) 14(22.22%) 36(70.6%) 15(29.4%) 0.38
Weight(Kg) (Mean ± S.D.) 47.58 ± 7.78 51.47 ± 9.58 0.01
BMI (kg/m 2 ) (Mean + S.D.) b 17.83 ± 4.44 19.15 ± 4.67 0.20
CD4 cell count (cells/mm 3 ) (Median, IQR) 127 (16-693) 142 (9 -252) 0.36
Viral Load (copies/ml) (Median, IQR) 161499 (129-6080000) Not done -
Haemoglobin (g/dl), (Mean + S.D.) 10.2 ± 2.08 11.5 ± 1.53 < 0.01
Bilirubin (mg/dl) (Mean + S.D.) 0.63 ± 0.17 0.64 ± 0.21 0.93
AST (I.U) (Mean + S.D.) 47.76 ± 39.37 38.79 ± 21.25 0.22
ALT (I.U.) (Mean + S.D.) 37.33 ± 32.55 35.26 ± 19.84 0.74
Albumin (g/dl) (Mean + S.D.) 3.72 ± 0.73 4.26 ± 0.57 < 0.001
  1. aInter Quartile Range
  2. bStandard deviation